Skip to main content
Premium Trial:

Request an Annual Quote

GATC Biotech's GATCLiquid

GATC Biotech has released a new liquid biopsy offering for early-access clinical research and product development called GATCLiquid Technology Suite. Based on next-gen sequencing and GATC's proprietary analysis techniques, the suite is aimed at the detection of genomic alterations in circulating DNA for diagnostic purposes, such as identifying clinically actionable genomic alterations that influence tumor development or treatment outcomes.

GATC says it has already sequenced more than 40,000 samples from blood and plasma, the majority under diagnostic conditions.

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.